# Digimarc Corp: financial statements, quarterly

DMRC · Nasdaq · CIK 2119322 · [Technology](/sectors/technology.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/dmrc.md) · [Financials](/companies/dmrc/financials.md) · [Filings](/companies/dmrc/filings.md) · [Insiders](/companies/dmrc/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/dmrc/financials.md?period=annual).

## Income statement

| Line item | Unit | period not labelled (2025-06-30) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: |
| Revenue | $m | [8.0](/filings/0001437749-26-028000.md) | [7.4](/filings/0001437749-26-028000.md) |
| Cost of revenue | $m | [3.3](/filings/0001437749-26-028000.md) | [3.1](/filings/0001437749-26-028000.md) |
| Gross profit | $m | [4.7](/filings/0001437749-26-028000.md) | [4.3](/filings/0001437749-26-028000.md) |
| Research and development | $m | [4.5](/filings/0001437749-26-028000.md) | [3.7](/filings/0001437749-26-028000.md) |
| Operating income | $m | [(8.4)](/filings/0001437749-26-028000.md) | [(12.4)](/filings/0001437749-26-028000.md) |
| Income tax | $m | [0.0](/filings/0001437749-26-028000.md) | [(0.0)](/filings/0001437749-26-028000.md) |
| Net income | $m | [(8.2)](/filings/0001437749-26-028000.md) | [(12.1)](/filings/0001437749-26-028000.md) |
| Diluted EPS | $ per share | [(0.38)](/filings/0001437749-26-028000.md) | [(0.54)](/filings/0001437749-26-028000.md) |
| Basic EPS | $ per share | [(0.38)](/filings/0001437749-26-028000.md) | [(0.54)](/filings/0001437749-26-028000.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Gross profit: us-gaap:GrossProfit
- Research and development: us-gaap:ResearchAndDevelopmentExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | period not labelled (2024-12-31) | period not labelled (2025-03-31) | period not labelled (2025-06-30) | period not labelled (2025-12-31) | period not labelled (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | not reported | not reported | not reported | [9.8](/filings/0001437749-26-028000.md) | not reported | [6.9](/filings/0001437749-26-028000.md) |
| Current assets | $m | not reported | not reported | not reported | [21.3](/filings/0001437749-26-028000.md) | not reported | [17.8](/filings/0001437749-26-028000.md) |
| Total assets | $m | not reported | not reported | not reported | [53.0](/filings/0001437749-26-028000.md) | not reported | [45.8](/filings/0001437749-26-028000.md) |
| Current liabilities | $m | not reported | not reported | not reported | [8.4](/filings/0001437749-26-028000.md) | not reported | [12.5](/filings/0001437749-26-028000.md) |
| Total liabilities | $m | not reported | not reported | not reported | [12.7](/filings/0001437749-26-028000.md) | not reported | [16.4](/filings/0001437749-26-028000.md) |
| Shareholders' equity | $m | [61.4](/filings/0001437749-26-028000.md) | [50.0](/filings/0001437749-26-028000.md) | [46.5](/filings/0001437749-26-028000.md) | [40.2](/filings/0001437749-26-028000.md) | [34.1](/filings/0001437749-26-028000.md) | [29.3](/filings/0001437749-26-028000.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Shareholders' equity: us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest, us-gaap:StockholdersEquity

## Shares

| Line item | Unit | period not labelled (2025-06-30) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [21.6](/filings/0001437749-26-028000.md) | [22.3](/filings/0001437749-26-028000.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 22,475,329 at 2026-08-07, from the cover of the [10-Q filed 2026-08-14](/filings/0001437749-26-028000.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:51 ET. No prices; not investment advice.